Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 488

1.

The Chinese Children and Families Cohort Study: The Nutrition, Physical Activity, and Ultraviolet Radiation Data Collection.

Potischman N, Fang L, Hao L, Bailey RR, Berrigan D, Berry RJ, Brodie A, Chao A, Chen J, Dodd K, Feng Y, Ma G, He Y, Fan J, Kimlin M, Kitahara C, Linet M, Li Z, Liu A, Liu Y, Sampson J, Su J, Sun J, Tasevska N, Yang L, Yang R, Zhang Q, Wang N, Wang L, Yu W.

Nutr Today. 2018 May-Jun;53(3):104-114. doi: 10.1097/NT.0000000000000275. Epub 2018 May 23.

PMID:
29930434
2.

Unusual presentation of Henöch-Schonlein purpura.

Brodie A, G N, Nitiahpapand R, Chowoo L.

BMJ Case Rep. 2018 May 30;2018. pii: bcr-2017-220129. doi: 10.1136/bcr-2017-220129.

PMID:
29848517
3.

Validation of Questionnaire and Diary Measures of Time Outdoors Against an Objective Measure of Personal Ultraviolet Radiation Exposure.

Cust AE, Fenton GL, Smit AK, Espinoza D, Dobbinson S, Brodie A, Dang HTC, Kimlin MG.

Photochem Photobiol. 2018 Feb 8. doi: 10.1111/php.12893. [Epub ahead of print]

PMID:
29421857
4.

A rare case of urethral prolapse in a postmenopausal woman.

Green J, Brodie A, Tassadaq T.

BMJ Case Rep. 2017 Oct 20;2017. pii: bcr-2017-222182. doi: 10.1136/bcr-2017-222182. No abstract available.

PMID:
29054901
5.

Novel Assay to Detect RNA Polymerase I Activity In Vivo.

Guner G, Sirajuddin P, Zheng Q, Bai B, Brodie A, Liu H, Af Hällström T, Kulac I, Laiho M, De Marzo AM.

Mol Cancer Res. 2017 May;15(5):577-584. doi: 10.1158/1541-7786.MCR-16-0246. Epub 2017 Jan 23.

6.

Investigating the patterns and determinants of seasonal variation in vitamin D status in Australian adults: the Seasonal D Cohort Study.

King L, Dear K, Harrison SL, van der Mei I, Brodie AM, Kimlin MG, Lucas RM.

BMC Public Health. 2016 Aug 26;16:892. doi: 10.1186/s12889-016-3582-z.

7.

Treatment with an orally bioavailable prodrug of 17β-estradiol alleviates hot flushes without hormonal effects in the periphery.

Merchenthaler I, Lane M, Sabnis G, Brodie A, Nguyen V, Prokai L, Prokai-Tatrai K.

Sci Rep. 2016 Aug 1;6:30721. doi: 10.1038/srep30721.

8.

How far from the SNP may the causative genes be?

Brodie A, Azaria JR, Ofran Y.

Nucleic Acids Res. 2016 Jul 27;44(13):6046-54. doi: 10.1093/nar/gkw500. Epub 2016 Jun 6.

9.

Unusual case of respiratory embarrassment secondary to tracheal compression by a dilated oesophagus in a patient with recurrent achalasia.

Brodie A, Okeahialam N, Farinella E.

BMJ Case Rep. 2016 May 4;2016. pii: bcr2016215247. doi: 10.1136/bcr-2016-215247.

10.

Evidence-Based Practice Knowledge, Perceptions, and Behavior: A Multi-Institutional, Cross-Sectional Study of a Population of U.S. Dental Students.

Straub-Morarend CL, Wankiiri-Hale CR, Blanchette DR, Lanning SK, Bekhuis T, Smith BM, Brodie AJ, Oliveira DC, Handysides RA, Dawson DV, Spallek H.

J Dent Educ. 2016 Apr;80(4):430-8.

11.

Combined Treatment with Epigenetic, Differentiating, and Chemotherapeutic Agents Cooperatively Targets Tumor-Initiating Cells in Triple-Negative Breast Cancer.

Merino VF, Nguyen N, Jin K, Sadik H, Cho S, Korangath P, Han L, Foster YMN, Zhou XC, Zhang Z, Connolly RM, Stearns V, Ali SZ, Adams C, Chen Q, Pan D, Huso DL, Ordentlich P, Brodie A, Sukumar S.

Cancer Res. 2016 Apr 1;76(7):2013-2024. doi: 10.1158/0008-5472.CAN-15-1619. Epub 2016 Jan 19.

12.

Seribantumab, an Anti-ERBB3 Antibody, Delays the Onset of Resistance and Restores Sensitivity to Letrozole in an Estrogen Receptor-Positive Breast Cancer Model.

Curley MD, Sabnis GJ, Wille L, Adiwijaya BS, Garcia G, Moyo V, Kazi AA, Brodie A, MacBeath G.

Mol Cancer Ther. 2015 Nov;14(11):2642-52. doi: 10.1158/1535-7163.MCT-15-0169. Epub 2015 Aug 26.

13.

The prodrug DHED selectively delivers 17β-estradiol to the brain for treating estrogen-responsive disorders.

Prokai L, Nguyen V, Szarka S, Garg P, Sabnis G, Bimonte-Nelson HA, McLaughlin KJ, Talboom JS, Conrad CD, Shughrue PJ, Gould TD, Brodie A, Merchenthaler I, Koulen P, Prokai-Tatrai K.

Sci Transl Med. 2015 Jul 22;7(297):297ra113. doi: 10.1126/scitranslmed.aab1290.

14.

Histone deacetylase inhibitor entinostat in combination with a retinoid downregulates HER2 and reduces the tumor initiating cell population in aromatase inhibitor-resistant breast cancer.

Schech AJ, Shah P, Yu S, Sabnis GJ, Goloubeva O, Rosenblatt P, Kazi A, Chumsri S, Brodie A.

Breast Cancer Res Treat. 2015 Aug;152(3):499-508. doi: 10.1007/s10549-015-3442-z. Epub 2015 Jul 2.

PMID:
26133921
15.

Aromatase Inhibitor-Mediated Downregulation of INrf2 (Keap1) Leads to Increased Nrf2 and Resistance in Breast Cancer.

Khatri R, Shah P, Guha R, Rassool FV, Tomkinson AE, Brodie A, Jaiswal AK.

Mol Cancer Ther. 2015 Jul;14(7):1728-37. doi: 10.1158/1535-7163.MCT-14-0672. Epub 2015 May 14.

16.

Nephroureterectomy for emphysematous pyelonephritis: An aggressive approach is sometimes necessary. A case report and literature review.

Nana GR, Brodie A, Akhter W, Karim O, Motiwala H.

Int J Surg Case Rep. 2015;10:179-82. doi: 10.1016/j.ijscr.2015.03.051. Epub 2015 Mar 28.

17.

Are the current Australian sun exposure guidelines effective in maintaining adequate levels of 25-hydroxyvitamin D?

Kimlin M, Sun J, Sinclair C, Heward S, Hill J, Dunstone K, Brodie A.

J Steroid Biochem Mol Biol. 2016 Jan;155(Pt B):264-70. doi: 10.1016/j.jsbmb.2015.03.007. Epub 2015 Mar 20. Review.

PMID:
25797374
18.

Discovery and development of Galeterone (TOK-001 or VN/124-1) for the treatment of all stages of prostate cancer.

Njar VC, Brodie AM.

J Med Chem. 2015 Mar 12;58(5):2077-87. doi: 10.1021/jm501239f. Epub 2015 Jan 28.

PMID:
25591066
19.

Combined cancer therapy: strategies to overcome acquired aromatase inhibitor resistance.

Kesmodel SB, Sabnis GJ, Chumsri S, Brodie AM.

Curr Pharm Des. 2014;20(42):6575-83. Review.

PMID:
25341934
20.

The relationship between ambient ultraviolet radiation (UVR) and objectively measured personal UVR exposure dose is modified by season and latitude.

Sun J, Lucas RM, Harrison S, van der Mei I, Armstrong BK, Nowak M, Brodie A, Kimlin MG.

Photochem Photobiol Sci. 2014 Dec;13(12):1711-8. doi: 10.1039/c4pp00322e. Epub 2014 Oct 14.

PMID:
25311529
21.

The bladder or not the bladder that is the question!

Jalil R, Jahan KA, Brodie A, Kalsi J.

BMJ Case Rep. 2014 Aug 25;2014. pii: bcr2014206316. doi: 10.1136/bcr-2014-206316. No abstract available.

22.

Large scale analysis of phenotype-pathway relationships based on GWAS results.

Brodie A, Tovia-Brodie O, Ofran Y.

PLoS One. 2014 Jul 9;9(7):e100887. doi: 10.1371/journal.pone.0100887. eCollection 2014.

23.

The modified mallet splint for closed central slip injuries.

Brodie A, Tan J.

Ann R Coll Surg Engl. 2014 Apr;96(3):247-8. doi: 10.1308/rcsann.2014.96.3.247b. No abstract available.

24.

The contributions of solar ultraviolet radiation exposure and other determinants to serum 25-hydroxyvitamin D concentrations in Australian adults: the AusD Study.

Kimlin MG, Lucas RM, Harrison SL, van der Mei I, Armstrong BK, Whiteman DC, Kricker A, Nowak M, Brodie AM, Sun J.

Am J Epidemiol. 2014 Apr 1;179(7):864-74. doi: 10.1093/aje/kwt446. Epub 2014 Feb 25.

PMID:
24573539
25.

Measuring exposure to solar ultraviolet radiation using a dosimetric technique: understanding participant compliance issues.

Sun J, Lucas RM, Harrison SL, van der Mei I, Whiteman DC, Mason R, Nowak M, Brodie AM, Kimlin MG.

Photochem Photobiol. 2014 Jul-Aug;90(4):919-24. doi: 10.1111/php.12265. Epub 2014 Mar 24.

PMID:
24571445
26.

mTOR inhibitors: changing landscape of endocrine-resistant breast cancer.

Chumsri S, Sabnis G, Tkaczuk K, Brodie A.

Future Oncol. 2014 Feb;10(3):443-56. doi: 10.2217/fon.13.178. Review.

PMID:
24559450
27.

Advances in mechanisms of resistance to aromatase inhibitors.

Chumsri S, Schech A, Chakkabat C, Sabnis G, Brodie A.

Expert Rev Anticancer Ther. 2014 Apr;14(4):381-93. doi: 10.1586/14737140.2014.882233. Epub 2014 Feb 22. Review.

PMID:
24559291
28.

Nonhypoxic regulation and role of hypoxia-inducible factor 1 in aromatase inhibitor resistant breast cancer.

Kazi AA, Gilani RA, Schech AJ, Chumsri S, Sabnis G, Shah P, Goloubeva O, Kronsberg S, Brodie AH.

Breast Cancer Res. 2014 Jan 29;16(1):R15. doi: 10.1186/bcr3609.

29.

Taking ergonomics to the bedside--a multi-disciplinary approach to designing safer healthcare.

Norris B, West J, Anderson O, Davey G, Brodie A.

Appl Ergon. 2014 May;45(3):629-38. doi: 10.1016/j.apergo.2013.09.004. Epub 2013 Oct 14.

PMID:
24135560
30.

HDAC inhibitor entinostat restores responsiveness of letrozole-resistant MCF-7Ca xenografts to aromatase inhibitors through modulation of Her-2.

Sabnis GJ, Goloubeva OG, Kazi AA, Shah P, Brodie AH.

Mol Cancer Ther. 2013 Dec;12(12):2804-16. doi: 10.1158/1535-7163.MCT-13-0345. Epub 2013 Oct 3.

31.

Zoledronic acid reverses the epithelial-mesenchymal transition and inhibits self-renewal of breast cancer cells through inactivation of NF-κB.

Schech AJ, Kazi AA, Gilani RA, Brodie AH.

Mol Cancer Ther. 2013 Jul;12(7):1356-66. doi: 10.1158/1535-7163.MCT-12-0304. Epub 2013 Apr 25.

32.

The AusD Study: a population-based study of the determinants of serum 25-hydroxyvitamin D concentration across a broad latitude range.

Brodie AM, Lucas RM, Harrison SL, van der Mei IA, Armstrong B, Kricker A, Mason RS, McMichael AJ, Nowak M, Whiteman DC, Kimlin MG.

Am J Epidemiol. 2013 May 1;177(9):894-903. doi: 10.1093/aje/kws322. Epub 2013 Mar 22.

PMID:
23524036
33.

Effect of selumetinib on the growth of anastrozole-resistant tumors.

Sabnis GJ, Kazi A, Golubeva O, Shah P, Brodie A.

Breast Cancer Res Treat. 2013 Apr;138(3):699-708. doi: 10.1007/s10549-013-2474-5. Epub 2013 Mar 19.

PMID:
23508762
34.

Obesity, energy balance, and cancer: new opportunities for prevention.

Hursting SD, Digiovanni J, Dannenberg AJ, Azrad M, Leroith D, Demark-Wahnefried W, Kakarala M, Brodie A, Berger NA.

Cancer Prev Res (Phila). 2012 Nov;5(11):1260-72. doi: 10.1158/1940-6207.CAPR-12-0140. Epub 2012 Oct 3. Review.

35.

Zinc, cadmium, and mercury complexes of a pyridyloxy-substituted cyclotriphosphazene: syntheses, structures, and fluxional behavior.

Ainscough EW, Brodie AM, Edwards PJ, Jameson GB, Otter CA, Kirk S.

Inorg Chem. 2012 Oct 15;51(20):10884-92. doi: 10.1021/ic3013574. Epub 2012 Oct 1.

PMID:
23025919
36.

The importance of HER2 signaling in the tumor-initiating cell population in aromatase inhibitor-resistant breast cancer.

Gilani RA, Kazi AA, Shah P, Schech AJ, Chumsri S, Sabnis G, Jaiswal AK, Brodie AH.

Breast Cancer Res Treat. 2012 Oct;135(3):681-92. doi: 10.1007/s10549-012-2148-8. Epub 2012 Aug 10.

PMID:
22878889
37.

Toward an iron(II) spin-crossover grafted phosphazene polymer.

Davidson RJ, Ainscough EW, Brodie AM, Jameson GB, Waterland MR, Allcock HR, Hindenlang MD, Moubaraki B, Murray KS, Gordon KC, Horvath R, Jameson GN.

Inorg Chem. 2012 Aug 6;51(15):8307-16. doi: 10.1021/ic300853f. Epub 2012 Jul 10.

PMID:
22780572
38.

Zoledronic acid inhibits aromatase activity and phosphorylation: potential mechanism for additive zoledronic acid and letrozole drug interaction.

Schech AJ, Nemieboka BE, Brodie AH.

J Steroid Biochem Mol Biol. 2012 Nov;132(3-5):195-202. doi: 10.1016/j.jsbmb.2012.05.008. Epub 2012 Jun 1.

39.

A systematic proactive risk assessment of hazards in surgical wards: a quantitative study.

Anderson O, Brodie A, Vincent CA, Hanna GB.

Ann Surg. 2012 Jun;255(6):1086-92. doi: 10.1097/SLA.0b013e31824f5f36.

PMID:
22504280
40.

Hormones in normal and cancerous breast: basic and clinical applications.

Brodie A, Russo J, Pasqualini JR.

Horm Mol Biol Clin Investig. 2012 Apr 1;9(1):1. doi: 10.1515/hmbci-2012-0021. No abstract available.

PMID:
25961349
41.

Aromatase inhibitors and breast cancer.

Chumsri S, Brodie A.

Horm Mol Biol Clin Investig. 2012 Apr;9(2):119-26. doi: 10.1515/hmbci-2012-0001.

PMID:
25436703
42.

Targeting abnormal DNA repair in therapy-resistant breast cancers.

Tobin LA, Robert C, Nagaria P, Chumsri S, Twaddell W, Ioffe OB, Greco GE, Brodie AH, Tomkinson AE, Rassool FV.

Mol Cancer Res. 2012 Jan;10(1):96-107. doi: 10.1158/1541-7786.MCR-11-0255. Epub 2011 Nov 23.

43.

Dual IGF-1R/InsR inhibitor BMS-754807 synergizes with hormonal agents in treatment of estrogen-dependent breast cancer.

Hou X, Huang F, Macedo LF, Harrington SC, Reeves KA, Greer A, Finckenstein FG, Brodie A, Gottardis MM, Carboni JM, Haluska P.

Cancer Res. 2011 Dec 15;71(24):7597-607. doi: 10.1158/0008-5472.CAN-11-1080. Epub 2011 Oct 31.

44.

Premature ejaculation and other sexual dysfunctions in opiate dependent men receiving methadone substitution treatment.

Chekuri V, Gerber D, Brodie A, Krishnadas R.

Addict Behav. 2012 Jan;37(1):124-6. doi: 10.1016/j.addbeh.2011.08.005. Epub 2011 Aug 25.

PMID:
21920671
45.

Novel membrane-associated androgen receptor splice variant potentiates proliferative and survival responses in prostate cancer cells.

Yang X, Guo Z, Sun F, Li W, Alfano A, Shimelis H, Chen M, Brodie AM, Chen H, Xiao Z, Veenstra TD, Qiu Y.

J Biol Chem. 2011 Oct 14;286(41):36152-60. doi: 10.1074/jbc.M111.265124. Epub 2011 Aug 30.

46.

Synthesis and biological evaluations of putative metabolically stable analogs of VN/124-1 (TOK-001): head to head anti-tumor efficacy evaluation of VN/124-1 (TOK-001) and abiraterone in LAPC-4 human prostate cancer xenograft model.

Bruno RD, Vasaitis TS, Gediya LK, Purushottamachar P, Godbole AM, Ates-Alagoz Z, Brodie AM, Njar VC.

Steroids. 2011 Nov;76(12):1268-79. doi: 10.1016/j.steroids.2011.06.002. Epub 2011 Jun 24.

47.

GP88 (PC-Cell Derived Growth Factor, progranulin) stimulates proliferation and confers letrozole resistance to aromatase overexpressing breast cancer cells.

Abrhale T, Brodie A, Sabnis G, Macedo L, Tian C, Yue B, Serrero G.

BMC Cancer. 2011 Jun 9;11:231. doi: 10.1186/1471-2407-11-231.

48.

Evaluating postdoctoral dental candidates: assessing the need and recommendations for a national qualifying examination.

Brodie AJ, Crow HC, Eber RM, Handysides R, Holexa R, Kiat-amnuay S, Spallek H.

J Dent Educ. 2011 Jun;75(6):719-25.

49.

Aromatase inhibitors and xenograft studies.

Chumsri S, Sabnis GJ, Howes T, Brodie AM.

Steroids. 2011 Jul;76(8):730-5. doi: 10.1016/j.steroids.2011.02.033. Epub 2011 Mar 21.

50.

Adaptive changes result in activation of alternate signaling pathways and acquisition of resistance to aromatase inhibitors.

Brodie A, Sabnis G.

Clin Cancer Res. 2011 Jul 1;17(13):4208-13. doi: 10.1158/1078-0432.CCR-10-2920. Epub 2011 Mar 17.

Supplemental Content

Loading ...
Support Center